PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors.

H S Gabryś,L Basler,S Burgermeister,S Hogan, M Ahmadsei,M Pavic,M Bogowicz,D Vuong, S Tanadini-Lang,R Förster, K Kudura, M Huellner, R Dummer,M P Levesque,M Guckenberger

Frontiers in oncology（2022）

引用 3|浏览22

暂无评分

摘要

FDG-PET/CT-based radiomic signatures yield potential for pretreatment prediction of lesion hyperprogression, which may contribute to reducing the risk of delayed treatment adaptation in metastatic melanoma patients treated with ICI.

查看译文

关键词

PET/CT,hyperprogression,immune checkpoint inhibition,melanoma,radiomics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要